Owkin Stock
Owkin is an AI biotechnology company that uses AI to find the right treatment for every patient. Their mission is to understand complex biology and derive new multimodal biomarkers through AI.
Sign up for SecondMarket™ to view the market and buy or sell Owkin Stock
Buy + SellOwkin Funding
Sign up to gain insights into Owkin funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the Data| Date | Financing Round | Amount | Price per share* | Valuation* |
|---|---|---|---|---|
| Jun 07, 2022 | Series B | 80.00M | ||
| Dec 15, 2021 | Series B | 180.00M | ||
| May 01, 2020 | Series A | 25.00M | ||
| Apr 17, 2019 | Series A | 13.04M | ||
| May 08, 2018 | Series A | 5.00M | ||
| Feb 14, 2018 | Series A | 11.02M | ||
| Jan 16, 2018 | Series Seed | 2.10M |
See Owkin Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Owkin Stock Valuation + Share Prices
View real-time Tape D™ data on Owkin stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get Started
Owkin Management Team
Chief Marketing Officer
Darius Meadon
Director
Laurent Higueret
Director
Alex Pasteur
Director
Nicole Junkermann
Director
Jacky Abitbol
Director
Bruno Strigini
Chief Diagnostics Officer
Meriem Sefta
Chief Operating Officer
Alban de la Sablière
Chief People Officer
Mariabrisa Olivares
Director
Jérôme Pesenti
Chief Medical Officer
Vassili Soumelis
Director
Jean-Jacques Bienaime
Chief Research and Development Officer
Jean-Philippe Vert
Chief Financial Officer
Andreas Emmenegger
Director
Bruno Raillard
Co-Founder, CEO, Director
Thomas Clozel
Owkin Major Investors
MACSF
Bpifrance Investissement SAS
Sanofi Ventures
Plug and Play Tech Center
Otium Capital
Bristol-Myers Squibb Company
NJF Capital
F-Prime Capital Partners
Eight Roads Ventures
Google Ventures (GV)
Cathay Innovation
Learn More About Owkin Stock
Buy Owkin Stock
01Owkin stock does not trade on public stock exchanges. Owkin stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Owkin stock you can either buy shares directly through company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell Owkin Stock
02Owkin Stock does not trade on public stock exchanges. In order to sell Owkin shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Owkin Stock Price
03Owkin does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Owkin share price and other valuable private market data.
Read more about secondary market private company stock prices:
Owkin Stock Ticker Symbol
04There is no ticker symbol for Owkin stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell Owkin Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Owkin stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in Owkin Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Owkin stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Owkin Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Owkin IPO
08Owkin is a private company and has not had an IPO. There is currently no Owkin IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Owkin IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket™ to view the market and buy or sell Owkin Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.
